Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06292169 · ClinicalTrials.gov registry record · NA
Pectoralis Minor Release Versus Non-release in RSA
A NA study of Rotator Cuff Tear Arthropathy and Reverse Total Shoulder Arthroplasty, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 2
- Study locations
NCT06292169 is a NA study of Rotator Cuff Tear Arthropathy and Reverse Total Shoulder Arthroplasty that is actively recruiting participants, run by Emory University. The registered enrollment target is 90 participants, below the 3,447-participant average among 6 other Rotator Cuff Tear Arthropathy trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06292169, a NA study of Rotator Cuff Tear Arthropathy and Reverse Total Shoulder Arthroplasty, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to assess if concomitant open pectoralis minor release would improve pain and outcomes after Reverse Shoulder Arthroplasty (RSA). The main questions it aims to answer are: * whether releasing the pectoralis minor prophylactically could have better pain relief * whether releasing the pectoralis minor prophylactically could have increased Range of motion (ROM) outcomes * whether releasing the pectoralis minor prophylactically could have higher final Patient Reported Outcome Measurements (PROMs) Participants will be randomized to either undergo RSA with pectoralis minor release or RSA without pectoralis minor release.
Conditions Studied
Interventions
- PROCEDURE Pectoralis Minor Release
- PROCEDURE RSA
Study Locations (2)
Georgia
- Emory Clinic - Atlanta
- Emory Healthcare Orthopaedics and Spine Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-08-07 |
| Est. Completion | 2026-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06292169
The ClinicalTrials.gov registry entry for NCT06292169 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,447-participant average among 6 other Rotator Cuff Tear Arthropathy trials with a reported enrollment target (97% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Rotator Cuff Tear Arthropathy appearing as the primary indexed condition, and to 2 interventions - of which Pectoralis Minor Release is the first listed.
NCT06292169 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT06292169 about?
NCT06292169 is a clinical study titled "Pectoralis Minor Release Versus Non-release in RSA". The goal of this clinical trial is to assess if concomitant open pectoralis minor release would improve pain and outcomes after Reverse Shoulder Arthroplasty (RSA). The main questions it aims to answer are: * whether releasing the pectoralis minor prophylactically could have better pain relief * wh...
What is the current status of trial NCT06292169?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-08-07. Estimated completion is 2026-01.
What conditions does trial NCT06292169 study?
This clinical trial studies the following conditions: Rotator Cuff Tear Arthropathy, Reverse Total Shoulder Arthroplasty, Advanced Glenohumeral Osteoarthritis.
What interventions are being tested in trial NCT06292169?
The interventions under investigation include: Pectoralis Minor Release (PROCEDURE), RSA (PROCEDURE).
Who is sponsoring clinical trial NCT06292169?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06292169 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tear Arthropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sling vs No Sling After Reverse Total Shoulder Arthroplasty
ACTIVE NOT RECRUITING · NA
-
Telerehabilitation After Shoulder Arthroplasty
ACTIVE NOT RECRUITING · NA
-
Effect of Ibuprofen on Postoperative Opiate Medication Use and Shoulder Functional Outcomes
COMPLETED · NA
-
Bioinductive Patch for Full-Thickness Rotator Cuff Tears
RECRUITING · Phase 4
-
Perform Humeral System Study
RECRUITING
-
Exactech Shoulder Post Market Clinical Follow-up Study
RECRUITING
Explore more on PlainTrial
Rotator Cuff Tear Arthropathy
All registered trials for this condition
Reverse Total Shoulder Arthroplasty
All registered trials for this condition
Georgia
All trials with a study site in Georgia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.